Interaction of Carthamus tinctorius lignan arctigenin with the binding site of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 450-452

  Temml, Veronika ^a   Kuehnl, Susanne ^a   Schuster, Daniela ^a   Schwaiger, Stefan ^a   Stuppner, Hermann ^a   Fuchs, Dietmar ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Carthamus tinctorius; Indoleamine 2,3 dioxygenase; Lignan

Indexed keywords

ARCTIGENIN; INDOLEAMINE 2,3 DIOXYGENASE; TRACHELOGENIN;

ALGORITHM; ARTICLE; ATOM; BINDING SITE; CALCULATION; CRYSTAL STRUCTURE; DRUG BINDING; DRUG STRUCTURE; ENZYME ACTIVITY; IN VITRO STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SAFFLOWER; STRUCTURE ACTIVITY RELATION;

EID: 84887033600     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2013.08.008     Document Type: Article

References (25)

1. He H., Cui L., exec. editors. Pharmacopoeia of PRC, vol. 1, English edition. Beijing: China Medical Science and Technology Press; 2010, p. 89-90.
2. Zhao G., Gai Y., Chu W.J., Qin G.W., Guo L.H. A novel compound N(1),N(5)-(Z)-N(10)-(E)-tri-p-coumaroylspermidine isolated from Carthamus tinctorius L. and acting by serotonin transporter inhibition. J. Eur. Coll. Neuropsychopharmacol 2009, 19:749-758.
3. von Bruchhausen F. Hagers Enzyklopädie der Arzneistoffe und Drogen (4) 2007, 880-883. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart. 6th ed., vol. 3.
4. Chen Y., Guillemin G.J. Kynurenine pathway metabolites in humans: disease and healthy states. Int. J. Tryptophan Res. 2009, 2:1-19.
5. Schroecksnadel K., Wirleitner B., Winkler C., Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin. Chim. Acta 2006, 364:82-90.
6. Chen W., Liang X., Peterson A.J., Munn D.H., Blazar B.R. The indoleamine 23-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J. Immunol. 2008, 181:5396-5404.
7. Soliman H., Mediavilla-Varela M., Antonia S. Indoleamine 2,3-dioxygenase: is it an immune supressor?. Cancer J. 2010, 16:354-359.
8. Byrne G.I., Lehmann L.K., Kirschbaum J.G., Borden E.C., Lee C.M., Brown R.R. Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity. J. Interferon Res. 1986, 6:389-396.
9. Stone T.W. Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog. Neurobiol 2001, 64:185-218.
10. Takikawa O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism. Biochem Biophys Res Commun 2005, 338:12-19.
11. Jenny M., Klieber M., Zaknun D., Schroecksnadel S., Kurz K., Ledochowski M., Schennach H., Fuchs D. In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm. Res. 2011, 60:127-135.
12. Kuehnl S., Schroecksnadel S., Temml V., Gostner J.M., Schennach H., Schuster D., Schwaiger S., Rollinger J.M., Fuchs D., Stuppner H. Immune modulating effects of lig-nans from Carthamus tinctorius. Phytomedicine 2013, 20:1190-1195.
13. Accelrys Software Inc., Discovery studio modeling environment, Release 3.5, San Diego: Accelrys Software Inc.; 2012, http://accelrys.com/products/discovery-studio/.
14. Hawkins P.C., Skillman G.A., Warren G.L., Ellingson B.A., Stahl M.T. Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and Cambridge structural database. J. Chem. Inf. Model. 2010, 50:572-584.
15. Molecular Operating Environment (MOE), 2012.10; Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7; 2012.
16. 2 incorporation by a heme-containing dioxygenase. Proc. Natl. Acad. Sci. USA 2006, 103:2611-2616.
17. Wolber G., Langer T. LigandScout: 3-d pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J. Chem. Inf. Model. 2005, 45:160-169.
18. Naïm M., Bhat S., Rankin K.N., Dennis S., Chowdhury S.F., Siddiqi I., Drabik P., Sulea T., Bayly C.I., Jakalian A., Purisima E.O. Solvated interaction energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space. J. Chem. Inf. Model. 2007, 47:122-133.
19. Corbeil C.R., Williams C.I., Labute P. Variability in docking success rates due to dataset preparation. J. Comput. Aided Mol. Des. 2012, 26:775-786.
20. Damm-Ganamet K.L., Smith R.D., Dunbar J.B., Stuckey J.A., Carlson H.A. CSAR Benchmark Exercise 2011-2012: evaluation of results from docking and relative ranking of blinded congeneric Series. J. Chem. Inf. Model. 2013, 10.1021/ci400025f.
21. Wirleitner B., Schroecksnadel K., Winkler C., Schennach H., Fuchs D. Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Immunol. Lett. 2005, 100:159-163.
22. Maier E., Kurz K., Jenny M., Schennach H., Ueberall F., Fuchs D. Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro. Food Chem. Toxicol. 2010, 48:1950-1956.
23. Vottero E., Balgi A., Woods K., Tugendreich S., Melese T., Andersen R.J., Mauk A.G., Roberge M. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast. Biotechnol. J. 2006, 1:282-288.
24. Forouhar F., Anderson J.L., Mowat C.G., Vorobiev S.M., Hussain A., Abashidze M., Bruckmann C., Thackray S.J., Seetharaman J., Tucker T., Xiao R., Ma L.C., Zhao L., Acton T.B., Montelione G.T., Chapman S.K., Tong L. Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase. Proc. Natl. Acad. Sci. USA 2007, 104:473-478.
25. 2 incorporation by a heme-containing dioxygenase. Proc. Natl. Acad. Sci. USA 2006, 103:2611-2616.